Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-22-003764
Filing Date
2022-04-05
Accepted
2022-04-05 16:11:18
Documents
17

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2032864
2 GRAPHIC g292355g00a03.jpg GRAPHIC 149485
3 GRAPHIC g292355g00a04.jpg GRAPHIC 93605
4 GRAPHIC g292355g00a05.jpg GRAPHIC 86829
5 GRAPHIC g292355g00a06.jpg GRAPHIC 84496
6 GRAPHIC g292355g00a07.jpg GRAPHIC 60483
7 GRAPHIC g292355g00a08.jpg GRAPHIC 83850
8 GRAPHIC g292355g00a09.jpg GRAPHIC 101442
9 GRAPHIC g292355g00a10.jpg GRAPHIC 169856
10 GRAPHIC g292355g00a11.jpg GRAPHIC 75892
11 GRAPHIC g292355g00a12.jpg GRAPHIC 57519
12 GRAPHIC g292355g00a13.jpg GRAPHIC 83729
13 GRAPHIC g292355g00a14.jpg GRAPHIC 53247
14 GRAPHIC g292355g02s54.jpg GRAPHIC 54367
15 GRAPHIC g292355g10o97.jpg GRAPHIC 35413
16 GRAPHIC g292355g27d77.jpg GRAPHIC 149149
17 GRAPHIC g292355g72k76.jpg GRAPHIC 154754
  Complete submission text file 0000950123-22-003764.txt   4028749
Mailing Address 5505 MOREHOUSE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE, SUITE 300 SAN DIEGO CA 92121 (619) 937-2754
RayzeBio, Inc. (Filer) CIK: 0001825367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-06008 | Film No.: 22806895
SIC: 2834 Pharmaceutical Preparations